Top of this page
Skip navigation, go straight to the content
Financials 2012
UCB will disclose its financial interim reports on:
- 26 April 3-month report
- 1 August half-year report
- 29 October 9-month report
More information closer to the date.
2012 interim report
Milestones
- Vimpat® - epilepsy PGTCS - Phase 2 results
- Cimzia® - rheumatoid arthritis (Japan) - filing
- Cimzia® - psoriatic arthritis - Phase 3 results
- Cimzia® - rheumatoid arthritis - start of Phase 3 C-EARLY™ study
- Neupro® - Parkinson's disease & restless legs syndrome (U.S.) - approval
- CDP7851 - post-menopausal osteoporosis - start of Phase 3
- Cimzia® - ankylosing spondylitis - Phase 3 results
